Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-volume versus standard-volume bupivacaine for upper trunk block in shoulder surgery
PACTR202510543542850Phase 3Completed
- Sponsor
- Dr. Rabab Saber
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bupivacaine in Shoulder disorder and pain (2 arms), sponsored by Dr. Rabab Saber. Primary endpoint: Phrenic nerve palsy. Started Mar 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
Shoulder disorderpain
Beyond the preview
Go deeper on PACTR202510543542850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510543542850.